Exco InTouch has raised $5 million (3.2 million GBP) in a round led by Albion Ventures, with participation from Scottish Equity Partners, the company’s largest shareholder.
The Nottingham, England-based Exco is a clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England. It offers patient engagement and data collection, including patient-reported outcomes software for mobile devices. Initially, the company worked with clinical trials exclusively, but has later branched out to ongoing disease management programs with healthcare providers.
Aside from AstraZeneca, Exco has also worked with other big pharma companies. In 2012, it launched a project with Vodafone.
Before this latest round, Exco has raised $4.7 million (3 million GBP) in late 2011.
[Via: mobihealthnews]